Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India flag India · Delayed Price · Currency is INR
27.94
-0.03 (-0.11%)
At close: Feb 12, 2026

BOM:531015 Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Equivalents
14.3224.820.03000.75
Cash & Short-Term Investments
14.3224.820.03000.75
Cash Growth
20955.88%99196.00%733.33%--99.60%5485.27%
Accounts Receivable
52.899.53-0.360.360.36
Other Receivables
52.880.270.13--1.04
Receivables
105.779.790.130.360.361.4
Inventory
15.720.58----
Other Current Assets
58.4616.1-1.020.960.02
Total Current Assets
194.2651.290.161.381.332.17
Property, Plant & Equipment
0.380.410.450.50.560.62
Other Intangible Assets
--0.210.230.260.28
Other Long-Term Assets
--0---0
Total Assets
194.6451.70.812.112.143.08
Accounts Payable
65.896.291.033.294.714.65
Accrued Expenses
-0.311.211.99-0.49
Short-Term Debt
33.250.53.523.523.4923.29
Current Income Taxes Payable
0.39-0.22---
Other Current Liabilities
0.750.481.290.423.32.47
Total Current Liabilities
100.287.577.279.2111.4930.9
Long-Term Deferred Tax Liabilities
0.010.010.050.050.050.04
Other Long-Term Liabilities
------0
Total Liabilities
100.297.587.329.2611.5430.94
Common Stock
80.0852.3952.3952.3952.3952.39
Additional Paid-In Capital
----7.37.3
Retained Earnings
14.26-58.99-58.89-59.53-69.09-87.56
Comprehensive Income & Other
050.72-0---
Shareholders' Equity
94.3444.12-6.5-7.15-9.4-27.86
Total Liabilities & Equity
194.6451.70.812.112.143.08
Total Debt
33.250.53.523.523.4923.29
Net Cash (Debt)
-18.9424.33-3.5-3.52-3.49-22.54
Net Cash Per Share
-2.984.64-0.67-0.67-0.67-4.30
Filing Date Shares Outstanding
6.425.245.245.245.245.24
Total Common Shares Outstanding
6.425.245.245.245.245.24
Working Capital
93.9843.73-7.11-7.83-10.17-28.72
Book Value Per Share
14.708.42-1.24-1.36-1.79-5.32
Tangible Book Value
94.3444.12-6.71-7.38-9.66-28.14
Tangible Book Value Per Share
14.708.42-1.28-1.41-1.84-5.37
Machinery
----0.620.83
Source: S&P Global Market Intelligence. Standard template. Financial Sources.